fanta.bio Sample: CNhs11737
- Species
- human
- CRE Type
- ELA
- Cluster
- 2
- Cell Type Class
- Digestive_tract
23133 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1413 / 21815 (6.5%) | 464 / 218150 (0.2%) | −324.0 | −324.0 | 30.45 |
| HIF1A SRX11007095 | HK-2 Kidney | 2681 / 21815 (12.3%) | 1026 / 218150 (0.5%) | −324.0 | −324.0 | 26.13 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 2045 / 21815 (9.4%) | 836 / 218150 (0.4%) | −324.0 | −324.0 | 24.46 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 2048 / 21815 (9.4%) | 871 / 218150 (0.4%) | −324.0 | −324.0 | 23.51 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2958 / 21815 (13.6%) | 1283 / 218150 (0.6%) | −324.0 | −324.0 | 23.06 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 2839 / 21815 (13.0%) | 1280 / 218150 (0.6%) | −324.0 | −324.0 | 22.18 |
| FOXP1 SRX736067 | LNCAP Prostate | 2490 / 21815 (11.4%) | 1125 / 218150 (0.5%) | −324.0 | −324.0 | 22.13 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 520 / 21815 (2.4%) | 235 / 218150 (0.1%) | −324.0 | −324.0 | 22.13 |
| SCML2 SRX644728 | 293 Kidney | 1689 / 21815 (7.7%) | 840 / 218150 (0.4%) | −324.0 | −324.0 | 20.11 |
| HIF1A SRX20663235 | HK-2 Kidney | 607 / 21815 (2.8%) | 314 / 218150 (0.1%) | −324.0 | −324.0 | 19.33 |
| MYH11 SRX265221 | ME-1 Blood | 1081 / 21815 (5.0%) | 720 / 218150 (0.3%) | −324.0 | −324.0 | 15.01 |
| MED1 SRX9419945 | BT-474 Breast | 4674 / 21815 (21.4%) | 3122 / 218150 (1.4%) | −324.0 | −324.0 | 14.97 |
| MED1 SRX9419944 | BT-474 Breast | 4545 / 21815 (20.8%) | 3063 / 218150 (1.4%) | −324.0 | −324.0 | 14.84 |
| BRD4 SRX9419936 | BT-474 Breast | 4784 / 21815 (21.9%) | 3247 / 218150 (1.5%) | −324.0 | −324.0 | 14.73 |
| MED1 SRX9419946 | BT-474 Breast | 4790 / 21815 (22.0%) | 3260 / 218150 (1.5%) | −324.0 | −324.0 | 14.69 |
| BRD4 SRX9419935 | BT-474 Breast | 4591 / 21815 (21.0%) | 3128 / 218150 (1.4%) | −324.0 | −324.0 | 14.68 |
| MED1 SRX9419947 | BT-474 Breast | 4635 / 21815 (21.2%) | 3208 / 218150 (1.5%) | −324.0 | −324.0 | 14.45 |
| BRD4 SRX9419938 | BT-474 Breast | 4703 / 21815 (21.6%) | 3275 / 218150 (1.5%) | −324.0 | −324.0 | 14.36 |
| BRD4 SRX9419937 | BT-474 Breast | 4515 / 21815 (20.7%) | 3232 / 218150 (1.5%) | −324.0 | −324.0 | 13.97 |
| EZH2 SRX2146136 | LNCAP Prostate | 10955 / 21815 (50.2%) | 8953 / 218150 (4.1%) | −324.0 | −324.0 | 12.24 |
| BRD4 SRX736201 | 90-8TL Neural | 7800 / 21815 (35.8%) | 7752 / 218150 (3.6%) | −324.0 | −324.0 | 10.06 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 716 / 21815 (3.3%) | 750 / 218150 (0.3%) | −324.0 | −324.0 | 9.55 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 985 / 21815 (4.5%) | 1105 / 218150 (0.5%) | −324.0 | −324.0 | 8.91 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 2322 / 21815 (10.6%) | 3206 / 218150 (1.5%) | −324.0 | −324.0 | 7.24 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1673 / 21815 (7.7%) | 4632 / 218150 (2.1%) | −324.0 | −324.0 | 3.61 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 2179 / 21815 (10.0%) | 6326 / 218150 (2.9%) | −324.0 | −324.0 | 3.44 |
| Epitope tags SRX10549776 | K-562 Blood | 2001 / 21815 (9.2%) | 6466 / 218150 (3.0%) | −324.0 | −324.0 | 3.09 |
| KAT7 SRX101303 | RKO Digestive tract | 1945 / 21815 (8.9%) | 6409 / 218150 (2.9%) | −324.0 | −324.0 | 3.03 |
| AGO2 SRX4708039 | Hep G2 Liver | 2675 / 21815 (12.3%) | 9390 / 218150 (4.3%) | −324.0 | −324.0 | 2.85 |
| 5-mC SRX882970 | LNCAP Prostate | 3881 / 21815 (17.8%) | 19140 / 218150 (8.8%) | −324.0 | −324.0 | 2.03 |
| 5-mC SRX882968 | LNCAP Prostate | 3811 / 21815 (17.5%) | 18939 / 218150 (8.7%) | −324.0 | −324.0 | 2.01 |
| RELA SRX2207673 | HUVEC Cardiovascular | 1389 / 21815 (6.4%) | 33044 / 218150 (15.1%) | −324.0 | −324.0 | 0.42 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 1258 / 21815 (5.8%) | 31481 / 218150 (14.4%) | −324.0 | −324.0 | 0.40 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 1250 / 21815 (5.7%) | 31795 / 218150 (14.6%) | −324.0 | −324.0 | 0.39 |
| TCF12 SRX190356 | SK-N-SH Neural | 1004 / 21815 (4.6%) | 27654 / 218150 (12.7%) | −324.0 | −324.0 | 0.36 |
| SS18 SRX3468047 | Fibroblasts Others | 917 / 21815 (4.2%) | 26335 / 218150 (12.1%) | −324.0 | −324.0 | 0.35 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 857 / 21815 (3.9%) | 25466 / 218150 (11.7%) | −324.0 | −324.0 | 0.34 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 857 / 21815 (3.9%) | 25657 / 218150 (11.8%) | −324.0 | −324.0 | 0.33 |
| GATA3 SRX190194 | SK-N-SH Neural | 836 / 21815 (3.8%) | 25295 / 218150 (11.6%) | −324.0 | −324.0 | 0.33 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 826 / 21815 (3.8%) | 25236 / 218150 (11.6%) | −324.0 | −324.0 | 0.33 |
| PBX4 SRX2731658 | PC-3 Prostate | 1077 / 21815 (4.9%) | 34650 / 218150 (15.9%) | −324.0 | −324.0 | 0.31 |
| FOS SRX150478 | MCF 10A Breast | 783 / 21815 (3.6%) | 26398 / 218150 (12.1%) | −324.0 | −324.0 | 0.30 |
| FOS SRX150477 | MCF 10A Breast | 738 / 21815 (3.4%) | 25802 / 218150 (11.8%) | −324.0 | −324.0 | 0.29 |
| FOS SRX4192880 | MCF 10A Breast | 575 / 21815 (2.6%) | 20964 / 218150 (9.6%) | −324.0 | −324.0 | 0.27 |
| YAP1 SRX757325 | H2052 Lung | 719 / 21815 (3.3%) | 26894 / 218150 (12.3%) | −324.0 | −324.0 | 0.27 |
| YAP1 SRX757326 | H2052 Lung | 578 / 21815 (2.6%) | 24081 / 218150 (11.0%) | −324.0 | −324.0 | 0.24 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 693 / 21815 (3.2%) | 22434 / 218150 (10.3%) | −323.0 | −320.2 | 0.31 |
| TP53 SRX19538279 | Osteoblasts Bone | 549 / 21815 (2.5%) | 369 / 218150 (0.2%) | −322.3 | −319.5 | 14.88 |
| BRD1 SRX286203 | RKO Digestive tract | 1674 / 21815 (7.7%) | 5128 / 218150 (2.4%) | −321.7 | −318.8 | 3.26 |
| RELA SRX2207672 | HUVEC Cardiovascular | 1510 / 21815 (6.9%) | 34586 / 218150 (15.9%) | −321.5 | −318.7 | 0.44 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 789 / 21815 (3.6%) | 1144 / 218150 (0.5%) | −307.2 | −304.4 | 6.90 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 694 / 21815 (3.2%) | 825 / 218150 (0.4%) | −307.1 | −304.3 | 8.41 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 1268 / 21815 (5.8%) | 30510 / 218150 (14.0%) | −303.7 | −300.9 | 0.42 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 859 / 21815 (3.9%) | 24371 / 218150 (11.2%) | −301.8 | −299.0 | 0.35 |
| FOS SRX150517 | MCF 10A Breast | 644 / 21815 (3.0%) | 20915 / 218150 (9.6%) | −300.7 | −297.9 | 0.31 |
| RUNX1 SRX2513054 | 293 Kidney | 4221 / 21815 (19.3%) | 22685 / 218150 (10.4%) | −299.7 | −296.9 | 1.86 |
| FOS SRX150476 | MCF 10A Breast | 654 / 21815 (3.0%) | 20985 / 218150 (9.6%) | −297.8 | −295.0 | 0.31 |
| AGO2 SRX6783957 | Hep G2 Liver | 1714 / 21815 (7.9%) | 5653 / 218150 (2.6%) | −297.6 | −294.9 | 3.03 |
| BRPF3 SRX796084 | RKO Digestive tract | 2062 / 21815 (9.5%) | 7752 / 218150 (3.6%) | −294.7 | −291.9 | 2.66 |
| 5-mC SRX882965 | LNCAP Prostate | 3128 / 21815 (14.3%) | 14810 / 218150 (6.8%) | −294.2 | −291.5 | 2.11 |
| TP53 SRX19538274 | U2OS Bone | 451 / 21815 (2.1%) | 230 / 218150 (0.1%) | −293.2 | −290.4 | 19.61 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 834 / 21815 (3.8%) | 23655 / 218150 (10.8%) | −292.1 | −289.4 | 0.35 |
| BRPF3 SRX796086 | RKO Digestive tract | 1986 / 21815 (9.1%) | 7350 / 218150 (3.4%) | −290.7 | −287.9 | 2.70 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 2744 / 21815 (12.6%) | 12273 / 218150 (5.6%) | −288.9 | −286.1 | 2.24 |
| FOXA1 SRX4815198 | MCF-7 Breast | 1384 / 21815 (6.3%) | 31579 / 218150 (14.5%) | −288.1 | −285.4 | 0.44 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 1165 / 21815 (5.3%) | 28458 / 218150 (13.0%) | −288.1 | −285.4 | 0.41 |
| JUN SRX17561461 | LPS141 Adipocyte | 548 / 21815 (2.5%) | 18886 / 218150 (8.7%) | −287.3 | −284.6 | 0.29 |
| BRPF3 SRX796085 | RKO Digestive tract | 1471 / 21815 (6.7%) | 4475 / 218150 (2.1%) | −284.0 | −281.4 | 3.29 |
| TP53 SRX19538268 | U2OS Bone | 443 / 21815 (2.0%) | 237 / 218150 (0.1%) | −283.3 | −280.6 | 18.69 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 262 / 21815 (1.2%) | 13527 / 218150 (6.2%) | −281.6 | −278.9 | 0.19 |
| JUN SRX6582171 | GM07492 Others | 766 / 21815 (3.5%) | 22235 / 218150 (10.2%) | −281.5 | −278.8 | 0.34 |
| TP53 SRX19538276 | U2OS Bone | 443 / 21815 (2.0%) | 242 / 218150 (0.1%) | −281.2 | −278.6 | 18.31 |
| AGO2 SRX6783958 | Hep G2 Liver | 1657 / 21815 (7.6%) | 5558 / 218150 (2.5%) | −280.3 | −277.7 | 2.98 |
| FOXA1 SRX176862 | MCF-7 Breast | 522 / 21815 (2.4%) | 18102 / 218150 (8.3%) | −276.4 | −273.7 | 0.29 |
| JUNB SRX8488073 | SUM 229PE Breast | 752 / 21815 (3.4%) | 21792 / 218150 (10.0%) | −274.8 | −272.1 | 0.35 |
| TP53 SRX19538280 | Osteoblasts Bone | 450 / 21815 (2.1%) | 274 / 218150 (0.1%) | −274.5 | −271.9 | 16.42 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 739 / 21815 (3.4%) | 1161 / 218150 (0.5%) | −271.4 | −268.8 | 6.37 |
| FOXA1 SRX4815197 | MCF-7 Breast | 1025 / 21815 (4.7%) | 25798 / 218150 (11.8%) | −271.0 | −268.4 | 0.40 |
| YAP1 SRX5718140 | 293 Kidney | 682 / 21815 (3.1%) | 20538 / 218150 (9.4%) | −270.5 | −267.8 | 0.33 |
| NR3C1 SRX2609664 | HASM2 Lung | 542 / 21815 (2.5%) | 18206 / 218150 (8.3%) | −269.1 | −266.5 | 0.30 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 370 / 21815 (1.7%) | 15208 / 218150 (7.0%) | −269.0 | −266.4 | 0.24 |
| PBX3 SRX190343 | SK-N-SH Neural | 861 / 21815 (3.9%) | 23221 / 218150 (10.6%) | −267.4 | −264.8 | 0.37 |
| EP300 SRX2671813 | Fibroblasts Others | 294 / 21815 (1.3%) | 13728 / 218150 (6.3%) | −266.9 | −264.3 | 0.21 |
| TP53 SRX19538267 | U2OS Bone | 408 / 21815 (1.9%) | 205 / 218150 (0.1%) | −266.5 | −263.9 | 19.90 |
| JUN SRX6582172 | Fibroblasts Others | 513 / 21815 (2.4%) | 17615 / 218150 (8.1%) | −265.9 | −263.3 | 0.29 |
| FOXA1 SRX176863 | MCF-7 Breast | 497 / 21815 (2.3%) | 17268 / 218150 (7.9%) | −263.4 | −260.9 | 0.29 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 808 / 21815 (3.7%) | 22260 / 218150 (10.2%) | −263.2 | −260.6 | 0.36 |
| ING5 SRX286202 | RKO Digestive tract | 1777 / 21815 (8.1%) | 6511 / 218150 (3.0%) | −263.0 | −260.4 | 2.73 |
| SMARCA2 SRX8119677 | MeT-5A Others | 670 / 21815 (3.1%) | 20040 / 218150 (9.2%) | −261.3 | −258.7 | 0.33 |
| JUNB SRX8488088 | SUM 229PE Breast | 815 / 21815 (3.7%) | 22279 / 218150 (10.2%) | −260.7 | −258.1 | 0.37 |
| TP53 SRX19538275 | U2OS Bone | 412 / 21815 (1.9%) | 229 / 218150 (0.1%) | −259.9 | −257.4 | 17.99 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 809 / 21815 (3.7%) | 22148 / 218150 (10.2%) | −259.5 | −257.0 | 0.37 |
| ESR1 SRX7624157 | MCF-7 Breast | 1117 / 21815 (5.1%) | 26704 / 218150 (12.2%) | −259.3 | −256.7 | 0.42 |
| FOSL2 SRX190296 | SK-N-SH Neural | 537 / 21815 (2.5%) | 17786 / 218150 (8.2%) | −258.6 | −256.0 | 0.30 |
| SMARCA4 SRX5212362 | Mel270 Others | 718 / 21815 (3.3%) | 20691 / 218150 (9.5%) | −258.2 | −255.7 | 0.35 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 1068 / 21815 (4.9%) | 25932 / 218150 (11.9%) | −257.5 | −254.9 | 0.41 |
| JUND SRX190357 | SK-N-SH Neural | 507 / 21815 (2.3%) | 17217 / 218150 (7.9%) | −256.6 | −254.0 | 0.29 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 283 / 21815 (1.3%) | 13213 / 218150 (6.1%) | −256.5 | −254.0 | 0.21 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 618 / 21815 (2.8%) | 19032 / 218150 (8.7%) | −256.1 | −253.6 | 0.32 |
| JUNB SRX10119386 | MCF 10A Breast | 342 / 21815 (1.6%) | 14249 / 218150 (6.5%) | −254.2 | −251.7 | 0.24 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 403 / 21815 (1.8%) | 15339 / 218150 (7.0%) | −253.9 | −251.4 | 0.26 |
| ESR1 SRX371478 | MCF-7 Breast | 550 / 21815 (2.5%) | 17837 / 218150 (8.2%) | −253.5 | −251.0 | 0.31 |
| EP300 SRX100540 | SK-N-SH Neural | 596 / 21815 (2.7%) | 18579 / 218150 (8.5%) | −253.3 | −250.7 | 0.32 |
| NR3C1 SRX2609665 | HASM2 Lung | 436 / 21815 (2.0%) | 15877 / 218150 (7.3%) | −252.5 | −250.0 | 0.27 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1806 / 21815 (8.3%) | 6853 / 218150 (3.1%) | −252.5 | −250.0 | 2.64 |
| TP53 SRX19538273 | U2OS Bone | 396 / 21815 (1.8%) | 214 / 218150 (0.1%) | −252.3 | −249.8 | 18.50 |
| GATA3 SRX190239 | MCF-7 Breast | 630 / 21815 (2.9%) | 19069 / 218150 (8.7%) | −251.4 | −248.9 | 0.33 |
| FOS SRX4192879 | MCF 10A Breast | 471 / 21815 (2.2%) | 16426 / 218150 (7.5%) | −250.9 | −248.4 | 0.29 |
| AR SRX10820653 | LNCAP Prostate | 404 / 21815 (1.9%) | 237 / 218150 (0.1%) | −249.9 | −247.4 | 17.05 |
| MAU2 SRX15710550 | Fibroblasts Others | 698 / 21815 (3.2%) | 20079 / 218150 (9.2%) | −249.4 | −246.9 | 0.35 |
| FOXA1 SRX3931044 | MCF-7 Breast | 949 / 21815 (4.4%) | 23866 / 218150 (10.9%) | −248.7 | −246.2 | 0.40 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 2264 / 21815 (10.4%) | 9865 / 218150 (4.5%) | −248.0 | −245.6 | 2.29 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 591 / 21815 (2.7%) | 18238 / 218150 (8.4%) | −245.4 | −242.9 | 0.32 |
| AR SRX1067071 | LHSAR Prostate | 866 / 21815 (4.0%) | 22475 / 218150 (10.3%) | −244.4 | −241.9 | 0.39 |
| TP53 SRX19538281 | Osteoblasts Bone | 463 / 21815 (2.1%) | 396 / 218150 (0.2%) | −244.3 | −241.8 | 11.69 |
| NR3C1 SRX2609666 | HASM2 Lung | 378 / 21815 (1.7%) | 14584 / 218150 (6.7%) | −243.8 | −241.4 | 0.26 |
| ESR1 SRX371476 | MCF-7 Breast | 305 / 21815 (1.4%) | 13249 / 218150 (6.1%) | −243.6 | −241.2 | 0.23 |
| JUNB SRX8488074 | SUM 229PE Breast | 562 / 21815 (2.6%) | 17709 / 218150 (8.1%) | −243.6 | −241.2 | 0.32 |
| FOXA1 SRX1161177 | MCF-7 Breast | 436 / 21815 (2.0%) | 15583 / 218150 (7.1%) | −243.2 | −240.8 | 0.28 |
| SMARCA4 SRX5212357 | Mel270 Others | 622 / 21815 (2.9%) | 18658 / 218150 (8.6%) | −243.0 | −240.6 | 0.33 |
| PRRX1 SRX15235713 | Hs 578T Breast | 511 / 21815 (2.3%) | 16814 / 218150 (7.7%) | −242.0 | −239.5 | 0.30 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 1297 / 21815 (5.9%) | 28582 / 218150 (13.1%) | −241.8 | −239.4 | 0.45 |
| SMARCA4 SRX5212366 | Mel270 Others | 576 / 21815 (2.6%) | 17858 / 218150 (8.2%) | −241.3 | −238.9 | 0.32 |
| ESR1 SRX20282961 | MCF-7 Breast | 563 / 21815 (2.6%) | 17640 / 218150 (8.1%) | −241.0 | −238.6 | 0.32 |
| FOXA1 SRX371482 | MCF-7 Breast | 650 / 21815 (3.0%) | 19028 / 218150 (8.7%) | −240.8 | −238.4 | 0.34 |
| NR3C1 SRX2609662 | HASM2 Lung | 500 / 21815 (2.3%) | 16565 / 218150 (7.6%) | −239.9 | −237.5 | 0.30 |
| SMARCA4 SRX5212371 | Mel270 Others | 611 / 21815 (2.8%) | 18375 / 218150 (8.4%) | −239.9 | −237.4 | 0.33 |
| ESR1 SRX371469 | MCF-7 Breast | 459 / 21815 (2.1%) | 15846 / 218150 (7.3%) | −239.2 | −236.8 | 0.29 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 686 / 21815 (3.1%) | 1155 / 218150 (0.5%) | −238.9 | −236.5 | 5.94 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 774 / 21815 (3.5%) | 20880 / 218150 (9.6%) | −238.7 | −236.3 | 0.37 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 1015 / 21815 (4.7%) | 24436 / 218150 (11.2%) | −238.0 | −235.6 | 0.42 |
| FOS SRX070879 | HUVEC Cardiovascular | 441 / 21815 (2.0%) | 15474 / 218150 (7.1%) | −237.0 | −234.6 | 0.28 |
| TP53 SRX396254 | Fibroblasts Others | 1167 / 21815 (5.3%) | 3401 / 218150 (1.6%) | −236.8 | −234.4 | 3.43 |
| EP300 SRX2671792 | Cardiac progenitor cells Cardiovascular | 289 / 21815 (1.3%) | 12724 / 218150 (5.8%) | −236.0 | −233.6 | 0.23 |
| JUN SRX4192884 | MCF 10A Breast | 338 / 21815 (1.5%) | 13621 / 218150 (6.2%) | −235.8 | −233.4 | 0.25 |
| TLE3 SRX4815191 | MCF-7 Breast | 429 / 21815 (2.0%) | 15224 / 218150 (7.0%) | −235.7 | −233.3 | 0.28 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 383 / 21815 (1.8%) | 14422 / 218150 (6.6%) | −235.7 | −233.3 | 0.27 |
| ESR1 SRX4367193 | MCF-7 Breast | 1470 / 21815 (6.7%) | 30700 / 218150 (14.1%) | −235.6 | −233.2 | 0.48 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 611 / 21815 (2.8%) | 18190 / 218150 (8.3%) | −234.4 | −232.0 | 0.34 |
| NR3C1 SRX2609659 | HASM2 Lung | 498 / 21815 (2.3%) | 16318 / 218150 (7.5%) | −233.5 | −231.2 | 0.31 |
| FOXL2 SRX6957431 | KGN Gonad | 1040 / 21815 (4.8%) | 24616 / 218150 (11.3%) | −233.2 | −230.9 | 0.42 |
| MEAF6 DRX300417 | 293 Kidney | 2009 / 21815 (9.2%) | 8473 / 218150 (3.9%) | −233.2 | −230.8 | 2.37 |
| ESR1 SRX176860 | MCF-7 Breast | 750 / 21815 (3.4%) | 20313 / 218150 (9.3%) | −233.1 | −230.7 | 0.37 |
| JUNB SRX4192882 | MCF 10A Breast | 322 / 21815 (1.5%) | 13241 / 218150 (6.1%) | −232.9 | −230.6 | 0.24 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 2457 / 21815 (11.3%) | 11504 / 218150 (5.3%) | −232.3 | −230.0 | 2.14 |
| ESR1 SRX176861 | MCF-7 Breast | 755 / 21815 (3.5%) | 20356 / 218150 (9.3%) | −232.0 | −229.7 | 0.37 |
| FOXA1 SRX371483 | MCF-7 Breast | 516 / 21815 (2.4%) | 16554 / 218150 (7.6%) | −231.6 | −229.2 | 0.31 |
| MEAF6 DRX234811 | 293 Kidney | 2170 / 21815 (9.9%) | 9565 / 218150 (4.4%) | −231.6 | −229.2 | 2.27 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 777 / 21815 (3.6%) | 20659 / 218150 (9.5%) | −231.1 | −228.8 | 0.38 |
| SMARCC1 SRX11379506 | Liposarcoma, Myxoid Adipocyte | 770 / 21815 (3.5%) | 20546 / 218150 (9.4%) | −231.0 | −228.7 | 0.37 |
| ESR1 SRX7624156 | MCF-7 Breast | 734 / 21815 (3.4%) | 19977 / 218150 (9.2%) | −230.5 | −228.1 | 0.37 |
| CIC SRX13262055 | Astrocytes Neural | 3795 / 21815 (17.4%) | 21406 / 218150 (9.8%) | −230.5 | −228.1 | 1.77 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 779 / 21815 (3.6%) | 20625 / 218150 (9.5%) | −229.4 | −227.1 | 0.38 |
| ESR1 SRX20282939 | MCF-7 Breast | 522 / 21815 (2.4%) | 16546 / 218150 (7.6%) | −228.4 | −226.0 | 0.32 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 798 / 21815 (3.7%) | 1691 / 218150 (0.8%) | −228.2 | −225.9 | 4.72 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 572 / 21815 (2.6%) | 17337 / 218150 (7.9%) | −227.7 | −225.4 | 0.33 |
| Epitope tags SRX11470449 | Mesenchymal stem cells Others | 668 / 21815 (3.1%) | 18853 / 218150 (8.6%) | −227.5 | −225.1 | 0.35 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 541 / 21815 (2.5%) | 16797 / 218150 (7.7%) | −226.5 | −224.2 | 0.32 |
| ESR1 SRX371479 | MCF-7 Breast | 423 / 21815 (1.9%) | 14826 / 218150 (6.8%) | −226.5 | −224.2 | 0.29 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 795 / 21815 (3.6%) | 20692 / 218150 (9.5%) | −224.6 | −222.3 | 0.38 |
| JUN SRX883584 | MDA-MB-231 Breast | 717 / 21815 (3.3%) | 19506 / 218150 (8.9%) | −224.5 | −222.2 | 0.37 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 660 / 21815 (3.0%) | 18621 / 218150 (8.5%) | −224.5 | −222.2 | 0.35 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 549 / 21815 (2.5%) | 16845 / 218150 (7.7%) | −224.0 | −221.7 | 0.33 |
| RELA SRX7055007 | HAEC Cardiovascular | 823 / 21815 (3.8%) | 21091 / 218150 (9.7%) | −223.9 | −221.6 | 0.39 |
| FOS SRX150664 | HUVEC Cardiovascular | 591 / 21815 (2.7%) | 17513 / 218150 (8.0%) | −223.8 | −221.5 | 0.34 |
| GATA3 SRX176864 | MCF-7 Breast | 324 / 21815 (1.5%) | 12978 / 218150 (5.9%) | −223.2 | −220.9 | 0.25 |
| FOXA1 SRX371481 | MCF-7 Breast | 498 / 21815 (2.3%) | 15978 / 218150 (7.3%) | −223.1 | −220.8 | 0.31 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 1026 / 21815 (4.7%) | 24032 / 218150 (11.0%) | −223.1 | −220.8 | 0.43 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 609 / 21815 (2.8%) | 17770 / 218150 (8.1%) | −223.1 | −220.8 | 0.34 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 1218 / 21815 (5.6%) | 26739 / 218150 (12.3%) | −223.1 | −220.8 | 0.46 |
| Epitope tags SRX11470532 | Mesenchymal stem cells Others | 586 / 21815 (2.7%) | 17403 / 218150 (8.0%) | −223.0 | −220.8 | 0.34 |
| Epitope tags DRX443510 | 293 Kidney | 1874 / 21815 (8.6%) | 7796 / 218150 (3.6%) | −222.5 | −220.2 | 2.40 |
| IRF3 SRX11453858 | Hep G2 Liver | 308 / 21815 (1.4%) | 111 / 218150 (0.1%) | −222.3 | −220.0 | 27.75 |
| EP300 SRX2194266 | SUM 159PT Breast | 787 / 21815 (3.6%) | 20487 / 218150 (9.4%) | −222.2 | −220.0 | 0.38 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 603 / 21815 (2.8%) | 17645 / 218150 (8.1%) | −222.1 | −219.8 | 0.34 |
| FOXA1 SRX1161176 | MCF-7 Breast | 441 / 21815 (2.0%) | 14980 / 218150 (6.9%) | −221.7 | −219.4 | 0.29 |
| NKX2-1 SRX2164786 | A549 Lung | 762 / 21815 (3.5%) | 20087 / 218150 (9.2%) | −221.6 | −219.3 | 0.38 |
| FOXA1 SRX1161173 | MCF-7 Breast | 363 / 21815 (1.7%) | 13623 / 218150 (6.2%) | −221.4 | −219.1 | 0.27 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 2088 / 21815 (9.6%) | 9225 / 218150 (4.2%) | −221.3 | −219.0 | 2.26 |
| ESR1 SRX20282960 | MCF-7 Breast | 538 / 21815 (2.5%) | 16570 / 218150 (7.6%) | −221.2 | −219.0 | 0.32 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 424 / 21815 (1.9%) | 14634 / 218150 (6.7%) | −219.9 | −217.7 | 0.29 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 451 / 21815 (2.1%) | 15075 / 218150 (6.9%) | −219.5 | −217.3 | 0.30 |
| ATF1 SRX11470450 | Mesenchymal stem cells Others | 885 / 21815 (4.1%) | 21843 / 218150 (10.0%) | −219.5 | −217.2 | 0.41 |
| CEBPB SRX150632 | HeLa Uterus | 1058 / 21815 (4.8%) | 24330 / 218150 (11.2%) | −219.0 | −216.8 | 0.43 |
| ESR1 SRX371471 | ZR-75-1 Breast | 515 / 21815 (2.4%) | 16114 / 218150 (7.4%) | −218.7 | −216.5 | 0.32 |
| JUN SRX6582163 | BJ-5ta Epidermis | 564 / 21815 (2.6%) | 16901 / 218150 (7.7%) | −218.6 | −216.4 | 0.33 |
| JUN SRX2355072 | HAEC Cardiovascular | 597 / 21815 (2.7%) | 17422 / 218150 (8.0%) | −218.4 | −216.2 | 0.34 |
| Epitope tags SRX10549778 | K-562 Blood | 1441 / 21815 (6.6%) | 5193 / 218150 (2.4%) | −217.4 | −215.2 | 2.77 |
| NR3C1 SRX2609661 | HASM2 Lung | 503 / 21815 (2.3%) | 15866 / 218150 (7.3%) | −217.3 | −215.0 | 0.32 |
| SS18 SRX10640842 | SK-MEL-147 Epidermis | 591 / 21815 (2.7%) | 17279 / 218150 (7.9%) | −217.1 | −214.8 | 0.34 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 304 / 21815 (1.4%) | 12424 / 218150 (5.7%) | −217.0 | −214.7 | 0.24 |
| TP53 SRX19538269 | U2OS Bone | 489 / 21815 (2.2%) | 578 / 218150 (0.3%) | −216.8 | −214.6 | 8.46 |
| GATA3 SRX5057632 | MCF-7 Breast | 290 / 21815 (1.3%) | 12163 / 218150 (5.6%) | −216.7 | −214.5 | 0.24 |
| JUN SRX7277180 | GM07492 Others | 363 / 21815 (1.7%) | 13477 / 218150 (6.2%) | −216.7 | −214.5 | 0.27 |
| TEAD1 SRX14688734 | HUVEC Cardiovascular | 374 / 21815 (1.7%) | 13658 / 218150 (6.3%) | −216.3 | −214.1 | 0.27 |
| AR SRX1067070 | LHSAR Prostate | 1155 / 21815 (5.3%) | 25564 / 218150 (11.7%) | −215.7 | −213.5 | 0.45 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 1402 / 21815 (6.4%) | 28957 / 218150 (13.3%) | −215.6 | −213.4 | 0.48 |
| AR SRX10820651 | LNCAP Prostate | 422 / 21815 (1.9%) | 386 / 218150 (0.2%) | −215.4 | −213.2 | 10.93 |
| ESR1 SRX1531791 | MCF-7 Breast | 459 / 21815 (2.1%) | 15065 / 218150 (6.9%) | −215.0 | −212.8 | 0.30 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 383 / 21815 (1.8%) | 13764 / 218150 (6.3%) | −214.8 | −212.6 | 0.28 |
| FOSL2 SRX10640864 | SK-MEL-147 Epidermis | 622 / 21815 (2.9%) | 17684 / 218150 (8.1%) | −214.6 | −212.4 | 0.35 |
| EP300 SRX2194265 | SUM 159PT Breast | 729 / 21815 (3.3%) | 19309 / 218150 (8.9%) | −213.9 | −211.7 | 0.38 |
| FOXA1 SRX1161175 | MCF-7 Breast | 347 / 21815 (1.6%) | 13100 / 218150 (6.0%) | −213.8 | −211.6 | 0.26 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 810 / 21815 (3.7%) | 20497 / 218150 (9.4%) | −213.1 | −210.9 | 0.40 |
| FOXA1 SRX100454 | T-47D Breast | 623 / 21815 (2.9%) | 17627 / 218150 (8.1%) | −212.6 | −210.4 | 0.35 |
| YAP1 SRX10119364 | MCF 10A Breast | 375 / 21815 (1.7%) | 13542 / 218150 (6.2%) | −212.2 | −210.0 | 0.28 |
| RELA SRX7054617 | HAEC Cardiovascular | 549 / 21815 (2.5%) | 16440 / 218150 (7.5%) | −212.1 | −209.9 | 0.33 |
| YAP1 SRX1038945 | IMR-90 Lung | 333 / 21815 (1.5%) | 12791 / 218150 (5.9%) | −211.7 | −209.5 | 0.26 |
| GATA2 SRX3503584 | Endometrial stromal cells Uterus | 505 / 21815 (2.3%) | 15702 / 218150 (7.2%) | −211.3 | −209.1 | 0.32 |
| FOXA1 SRX371480 | MCF-7 Breast | 315 / 21815 (1.4%) | 12453 / 218150 (5.7%) | −211.3 | −209.1 | 0.25 |
| ESR1 SRX20282954 | MCF-7 Breast | 525 / 21815 (2.4%) | 16015 / 218150 (7.3%) | −211.1 | −208.9 | 0.33 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 393 / 21815 (1.8%) | 13800 / 218150 (6.3%) | −210.5 | −208.3 | 0.28 |
| LEO1 SRX1873456 | SEM Blood | 1824 / 21815 (8.4%) | 7708 / 218150 (3.5%) | −209.8 | −207.6 | 2.37 |
| SMARCC1 SRX11379517 | Liposarcoma, Myxoid Adipocyte | 387 / 21815 (1.8%) | 13661 / 218150 (6.3%) | −209.4 | −207.2 | 0.28 |
| JUNB SRX10119383 | MCF 10A Breast | 304 / 21815 (1.4%) | 12187 / 218150 (5.6%) | −209.2 | −207.0 | 0.25 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 798 / 21815 (3.7%) | 20169 / 218150 (9.2%) | −209.1 | −206.9 | 0.40 |
| SS18 SRX10640843 | SK-MEL-147 Epidermis | 746 / 21815 (3.4%) | 19380 / 218150 (8.9%) | −208.7 | −206.5 | 0.38 |
| JUN SRX6582165 | BJ-5ta Epidermis | 906 / 21815 (4.2%) | 21721 / 218150 (10.0%) | −208.1 | −205.9 | 0.42 |
| FOSL2 SRX5054308 | Neural progenitor cells Neural | 327 / 21815 (1.5%) | 12541 / 218150 (5.7%) | −207.2 | −205.0 | 0.26 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 716 / 21815 (3.3%) | 18856 / 218150 (8.6%) | −206.9 | −204.7 | 0.38 |
| JUN SRX2355073 | HAEC Cardiovascular | 594 / 21815 (2.7%) | 16967 / 218150 (7.8%) | −206.7 | −204.5 | 0.35 |
| TP53 SRX2585782 | MDA-MB-231 Breast | 887 / 21815 (4.1%) | 21372 / 218150 (9.8%) | −206.2 | −204.1 | 0.42 |
| ESR1 SRX371467 | MCF-7 Breast | 516 / 21815 (2.4%) | 15703 / 218150 (7.2%) | −206.2 | −204.0 | 0.33 |
| ESR1 SRX20282972 | MCF-7 Breast | 550 / 21815 (2.5%) | 16246 / 218150 (7.4%) | −206.0 | −203.9 | 0.34 |
| SREBF2 SRX5359048 | HCC70 Breast | 2115 / 21815 (9.7%) | 9727 / 218150 (4.5%) | −206.0 | −203.8 | 2.17 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 778 / 21815 (3.6%) | 1786 / 218150 (0.8%) | −205.7 | −203.5 | 4.36 |
| JUNB SRX10119384 | MCF 10A Breast | 267 / 21815 (1.2%) | 11397 / 218150 (5.2%) | −205.7 | −203.5 | 0.23 |
| ESR1 SRX10365536 | MCF-7 Breast | 247 / 21815 (1.1%) | 11013 / 218150 (5.0%) | −205.3 | −203.2 | 0.22 |
| ESR1 SRX371470 | ZR-75-1 Breast | 455 / 21815 (2.1%) | 14659 / 218150 (6.7%) | −204.8 | −202.7 | 0.31 |
| ESR1 SRX371468 | MCF-7 Breast | 310 / 21815 (1.4%) | 12149 / 218150 (5.6%) | −204.5 | −202.4 | 0.26 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 1966 / 21815 (9.0%) | 8760 / 218150 (4.0%) | −204.0 | −201.9 | 2.24 |
| TP53 SRX19538270 | U2OS Bone | 467 / 21815 (2.1%) | 567 / 218150 (0.3%) | −203.7 | −201.6 | 8.24 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 438 / 21815 (2.0%) | 14338 / 218150 (6.6%) | −203.7 | −201.5 | 0.31 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 447 / 21815 (2.0%) | 14465 / 218150 (6.6%) | −203.0 | −200.9 | 0.31 |
| ESR1 SRX194569 | MCF-7 Breast | 521 / 21815 (2.4%) | 15675 / 218150 (7.2%) | −203.0 | −200.8 | 0.33 |
| EP300 SRX190219 | SK-N-SH Neural | 463 / 21815 (2.1%) | 14724 / 218150 (6.7%) | −202.8 | −200.7 | 0.31 |
| CEBPA SRX2630241 | Hep G2 Liver | 587 / 21815 (2.7%) | 16703 / 218150 (7.7%) | −202.3 | −200.1 | 0.35 |
| RELA SRX7054657 | HAEC Cardiovascular | 531 / 21815 (2.4%) | 15803 / 218150 (7.2%) | −202.1 | −199.9 | 0.34 |
| ESR1 SRX194572 | MCF-7 Breast | 309 / 21815 (1.4%) | 12058 / 218150 (5.5%) | −202.0 | −199.9 | 0.26 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 2256 / 21815 (10.3%) | 10787 / 218150 (4.9%) | −202.0 | −199.9 | 2.09 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 449 / 21815 (2.1%) | 14443 / 218150 (6.6%) | −201.3 | −199.2 | 0.31 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 385 / 21815 (1.8%) | 13349 / 218150 (6.1%) | −200.8 | −198.7 | 0.29 |
| CEBPB SRX150598 | IMR-90 Lung | 992 / 21815 (4.5%) | 22671 / 218150 (10.4%) | −200.7 | −198.6 | 0.44 |
| ESR1 SRX371477 | MCF-7 Breast | 232 / 21815 (1.1%) | 10586 / 218150 (4.9%) | −200.6 | −198.4 | 0.22 |
| SS18 SRX10640841 | SK-MEL-147 Epidermis | 701 / 21815 (3.2%) | 18396 / 218150 (8.4%) | −200.5 | −198.4 | 0.38 |
| FOXA2 SRX3230382 | Hep G2 Liver | 663 / 21815 (3.0%) | 17792 / 218150 (8.2%) | −199.8 | −197.7 | 0.37 |
| NFIC SRX190336 | SK-N-SH Neural | 687 / 21815 (3.1%) | 18159 / 218150 (8.3%) | −199.8 | −197.7 | 0.38 |
| JUN SRX6582164 | BJ-5ta Epidermis | 608 / 21815 (2.8%) | 16929 / 218150 (7.8%) | −199.5 | −197.3 | 0.36 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 528 / 21815 (2.4%) | 15628 / 218150 (7.2%) | −198.2 | −196.1 | 0.34 |
| Epitope tags SRX11470534 | Mesenchymal stem cells Others | 891 / 21815 (4.1%) | 21121 / 218150 (9.7%) | −198.2 | −196.0 | 0.42 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 2385 / 21815 (10.9%) | 11797 / 218150 (5.4%) | −197.9 | −195.7 | 2.02 |
| MECOM SRX23677885 | HNT-34 Blood | 2179 / 21815 (10.0%) | 10353 / 218150 (4.7%) | −197.6 | −195.5 | 2.10 |
| FOXA1 SRX3923514 | MCF-7 Breast | 507 / 21815 (2.3%) | 15261 / 218150 (7.0%) | −197.5 | −195.4 | 0.33 |
| JUND SRX699738 | HCASMC Cardiovascular | 683 / 21815 (3.1%) | 18012 / 218150 (8.3%) | −197.4 | −195.3 | 0.38 |
| FOXA1 SRX1161174 | MCF-7 Breast | 512 / 21815 (2.3%) | 15317 / 218150 (7.0%) | −196.7 | −194.6 | 0.33 |
| TRP47 SRX4548329 | THP-1 Blood | 3192 / 21815 (14.6%) | 17802 / 218150 (8.2%) | −196.5 | −194.4 | 1.79 |
| TAL1 SRX393516 | Primary endothelial cells Cardiovascular | 581 / 21815 (2.7%) | 16398 / 218150 (7.5%) | −196.3 | −194.2 | 0.35 |
| AR SRX1067066 | LHSAR Prostate | 1042 / 21815 (4.8%) | 23189 / 218150 (10.6%) | −195.9 | −193.8 | 0.45 |
| NANOG SRX10445309 | Neural crest cells Neural | 248 / 21815 (1.1%) | 10745 / 218150 (4.9%) | −195.8 | −193.7 | 0.23 |
| RELA SRX7054663 | HAEC Cardiovascular | 407 / 21815 (1.9%) | 13547 / 218150 (6.2%) | −195.4 | −193.3 | 0.30 |
| MED1 SRX4937342 | HCT 116 Digestive tract | 1681 / 21815 (7.7%) | 7057 / 218150 (3.2%) | −195.1 | −193.0 | 2.38 |
| FOSL2 SRX190204 | A549 Lung | 479 / 21815 (2.2%) | 14719 / 218150 (6.7%) | −194.9 | −192.8 | 0.33 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 500 / 21815 (2.3%) | 15055 / 218150 (6.9%) | −194.8 | −192.7 | 0.33 |
| RAC1 SRX10365543 | MCF-7 Breast | 264 / 21815 (1.2%) | 10989 / 218150 (5.0%) | −194.0 | −191.9 | 0.24 |
| SSRP1 SRX3436567 | HT-1080 Bone | 495 / 21815 (2.3%) | 711 / 218150 (0.3%) | −193.5 | −191.4 | 6.96 |
| SMARCA4 SRX8588623 | Pulmonary artery endothelial cells Cardiovascular | 702 / 21815 (3.2%) | 18139 / 218150 (8.3%) | −193.1 | −191.0 | 0.39 |
| MECOM SRX23677884 | HNT-34 Blood | 2137 / 21815 (9.8%) | 10167 / 218150 (4.7%) | −193.1 | −191.0 | 2.10 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 354 / 21815 (1.6%) | 12561 / 218150 (5.8%) | −193.0 | −190.9 | 0.28 |
| JUN SRX9350646 | Melanoma cell line Epidermis | 659 / 21815 (3.0%) | 17483 / 218150 (8.0%) | −192.9 | −190.9 | 0.38 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 449 / 21815 (2.1%) | 14152 / 218150 (6.5%) | −192.6 | −190.5 | 0.32 |
| JUNB SRX8488089 | SUM 229PE Breast | 500 / 21815 (2.3%) | 14975 / 218150 (6.9%) | −192.3 | −190.2 | 0.33 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 656 / 21815 (3.0%) | 17398 / 218150 (8.0%) | −191.9 | −189.8 | 0.38 |
| STAT1 SRX23678708 | K-562 Blood | 1897 / 21815 (8.7%) | 8560 / 218150 (3.9%) | −191.4 | −189.3 | 2.22 |
| JUN SRX150358 | HUVEC Cardiovascular | 310 / 21815 (1.4%) | 11731 / 218150 (5.4%) | −191.1 | −189.0 | 0.26 |
| RELA SRX7054609 | HAEC Cardiovascular | 392 / 21815 (1.8%) | 13151 / 218150 (6.0%) | −191.1 | −189.0 | 0.30 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 462 / 21815 (2.1%) | 14301 / 218150 (6.6%) | −190.8 | −188.7 | 0.32 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 1085 / 21815 (5.0%) | 3516 / 218150 (1.6%) | −190.7 | −188.6 | 3.09 |
| STAT3 SRX150630 | MCF 10A Breast | 455 / 21815 (2.1%) | 14184 / 218150 (6.5%) | −190.6 | −188.5 | 0.32 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 296 / 21815 (1.4%) | 156 / 218150 (0.1%) | −190.3 | −188.2 | 18.97 |
| FOXA1 SRX11222437 | MCF-7 Breast | 358 / 21815 (1.6%) | 12539 / 218150 (5.7%) | −190.1 | −188.0 | 0.29 |
| FOXA1 SRX100506 | Hep G2 Liver | 672 / 21815 (3.1%) | 17574 / 218150 (8.1%) | −190.0 | −187.9 | 0.38 |
| ESR1 SRX10365532 | MCF-7 Breast | 272 / 21815 (1.2%) | 10998 / 218150 (5.0%) | −189.6 | −187.5 | 0.25 |
| FOXA1 SRX190181 | A549 Lung | 346 / 21815 (1.6%) | 12301 / 218150 (5.6%) | −189.1 | −187.1 | 0.28 |
| STAT3 SRX150479 | MCF 10A Breast | 462 / 21815 (2.1%) | 14248 / 218150 (6.5%) | −189.1 | −187.0 | 0.32 |
| MED1 SRX4937338 | HCT 116 Digestive tract | 1754 / 21815 (8.0%) | 7656 / 218150 (3.5%) | −188.9 | −186.8 | 2.29 |
| TEAD4 SRX10640862 | SK-MEL-147 Epidermis | 772 / 21815 (3.5%) | 19018 / 218150 (8.7%) | −188.6 | −186.5 | 0.41 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 555 / 21815 (2.5%) | 15714 / 218150 (7.2%) | −188.6 | −186.5 | 0.35 |
| MITF SRX7368255 | Hermes 3C Epidermis | 1432 / 21815 (6.6%) | 28189 / 218150 (12.9%) | −188.3 | −186.2 | 0.51 |
| CEBPB SRX2194250 | SUM 159PT Breast | 603 / 21815 (2.8%) | 16455 / 218150 (7.5%) | −188.3 | −186.2 | 0.37 |
| MECOM SRX23677896 | HNT-34 Blood | 2608 / 21815 (12.0%) | 13659 / 218150 (6.3%) | −188.2 | −186.2 | 1.91 |
| ESR1 SRX2943591 | MCF-7 Breast | 358 / 21815 (1.6%) | 12477 / 218150 (5.7%) | −188.2 | −186.2 | 0.29 |
| TEAD4 SRX10640861 | SK-MEL-147 Epidermis | 537 / 21815 (2.5%) | 15401 / 218150 (7.1%) | −187.6 | −185.6 | 0.35 |
| BMI1 SRX7196721 | SF8628 Neural | 2102 / 21815 (9.6%) | 10050 / 218150 (4.6%) | −187.6 | −185.6 | 2.09 |
| Epitope tags SRX15939724 | RD Muscle | 431 / 21815 (2.0%) | 13684 / 218150 (6.3%) | −187.6 | −185.5 | 0.31 |
| FOXA1 SRX1787653 | MCF-7 Breast | 418 / 21815 (1.9%) | 13463 / 218150 (6.2%) | −187.4 | −185.4 | 0.31 |
| FOXA1 SRX3931043 | MCF-7 Breast | 528 / 21815 (2.4%) | 15244 / 218150 (7.0%) | −187.3 | −185.2 | 0.35 |
| JADE3 DRX300415 | 293 Kidney | 1877 / 21815 (8.6%) | 8513 / 218150 (3.9%) | −187.2 | −185.2 | 2.20 |
| WWTR1 SRX10119367 | MCF 10A Breast | 589 / 21815 (2.7%) | 16192 / 218150 (7.4%) | −187.0 | −185.0 | 0.36 |
| ARID1A SRX5089376 | MCF-7 Breast | 450 / 21815 (2.1%) | 13964 / 218150 (6.4%) | −186.5 | −184.5 | 0.32 |
| MECOM SRX23677897 | HNT-34 Blood | 2516 / 21815 (11.5%) | 13040 / 218150 (6.0%) | −186.2 | −184.1 | 1.93 |
| RAC1 SRX10365541 | MCF-7 Breast | 275 / 21815 (1.3%) | 10946 / 218150 (5.0%) | −186.1 | −184.1 | 0.25 |
| RELA SRX7054618 | HAEC Cardiovascular | 488 / 21815 (2.2%) | 14564 / 218150 (6.7%) | −186.0 | −184.0 | 0.34 |
| IRF3 SRX11453861 | Hep G2 Liver | 267 / 21815 (1.2%) | 110 / 218150 (0.1%) | −185.7 | −183.6 | 24.27 |
| FOXL2 SRX6957477 | KGN Gonad | 529 / 21815 (2.4%) | 15204 / 218150 (7.0%) | −185.6 | −183.6 | 0.35 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 992 / 21815 (4.5%) | 3071 / 218150 (1.4%) | −185.4 | −183.4 | 3.23 |
| Epitope tags SRX11470445 | Mesenchymal stem cells Others | 645 / 21815 (3.0%) | 16982 / 218150 (7.8%) | −185.1 | −183.1 | 0.38 |
| TCF21 DRX190655 | HCF Cardiovascular | 842 / 21815 (3.9%) | 19901 / 218150 (9.1%) | −185.0 | −183.0 | 0.42 |
| CEBPB SRX1027438 | Mesenchymal stem cells Others | 646 / 21815 (3.0%) | 16992 / 218150 (7.8%) | −185.0 | −183.0 | 0.38 |
| RELA SRX7054666 | HAEC Cardiovascular | 750 / 21815 (3.4%) | 18553 / 218150 (8.5%) | −185.0 | −182.9 | 0.40 |
| EP300 SRX150579 | HeLa Uterus | 329 / 21815 (1.5%) | 11873 / 218150 (5.4%) | −184.9 | −182.9 | 0.28 |
| SOX13 SRX2636248 | Hep G2 Liver | 704 / 21815 (3.2%) | 17866 / 218150 (8.2%) | −184.9 | −182.9 | 0.39 |
| BRD4 SRX736204 | 90-8TL Neural | 1093 / 21815 (5.0%) | 3641 / 218150 (1.7%) | −184.7 | −182.6 | 3.00 |
| SMARCA4 SRX027488 | hESC H9 Pluripotent stem cell | 123 / 21815 (0.6%) | 7908 / 218150 (3.6%) | −184.5 | −182.5 | 0.16 |
| GATA1 SRX4172744 | HCT 116 Digestive tract | 1884 / 21815 (8.6%) | 8634 / 218150 (4.0%) | −183.8 | −181.7 | 2.18 |
| FOXA1 SRX3931055 | MCF-7 Breast | 442 / 21815 (2.0%) | 13736 / 218150 (6.3%) | −183.8 | −181.7 | 0.32 |
| DAXX SRX1021630 | PC-3 Prostate | 516 / 21815 (2.4%) | 14920 / 218150 (6.8%) | −183.4 | −181.4 | 0.35 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 483 / 21815 (2.2%) | 14386 / 218150 (6.6%) | −183.2 | −181.2 | 0.34 |
| SMARCA4 SRX8588626 | Pulmonary artery endothelial cells Cardiovascular | 687 / 21815 (3.1%) | 17548 / 218150 (8.0%) | −183.2 | −181.2 | 0.39 |
| FOXA2 SRX100448 | Hep G2 Liver | 570 / 21815 (2.6%) | 15756 / 218150 (7.2%) | −183.1 | −181.1 | 0.36 |
| FOXA1 SRX11222441 | MCF-7 Breast | 401 / 21815 (1.8%) | 13022 / 218150 (6.0%) | −182.7 | −180.6 | 0.31 |
| STAT3 SRX150536 | MCF 10A Breast | 571 / 21815 (2.6%) | 15739 / 218150 (7.2%) | −182.2 | −180.2 | 0.36 |
| FOXA1 SRX3931054 | MCF-7 Breast | 492 / 21815 (2.3%) | 14496 / 218150 (6.6%) | −182.2 | −180.2 | 0.34 |
| NANOG SRX3288567 | hESC H9 Pluripotent stem cell | 170 / 21815 (0.8%) | 8824 / 218150 (4.0%) | −182.1 | −180.1 | 0.19 |
| TP53 SRX19538282 | Osteoblasts Bone | 390 / 21815 (1.8%) | 423 / 218150 (0.2%) | −181.8 | −179.8 | 9.22 |
| CEBPB SRX11379527 | Liposarcoma, Myxoid Adipocyte | 913 / 21815 (4.2%) | 20797 / 218150 (9.5%) | −181.8 | −179.8 | 0.44 |
| MITF SRX1555436 | 501A Epidermis | 2378 / 21815 (10.9%) | 12164 / 218150 (5.6%) | −181.4 | −179.4 | 1.95 |
| CDYL2 SRX8321653 | MCF-7 Breast | 2211 / 21815 (10.1%) | 10968 / 218150 (5.0%) | −181.3 | −179.3 | 2.02 |
| ESR1 SRX20282973 | MCF-7 Breast | 638 / 21815 (2.9%) | 16732 / 218150 (7.7%) | −181.1 | −179.1 | 0.38 |
| ARID5B SRX10475139 | Hep G2 Liver | 562 / 21815 (2.6%) | 15561 / 218150 (7.1%) | −181.1 | −179.1 | 0.36 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 2103 / 21815 (9.6%) | 10210 / 218150 (4.7%) | −181.0 | −179.0 | 2.06 |
| FOXA1 SRX11222442 | MCF-7 Breast | 345 / 21815 (1.6%) | 12015 / 218150 (5.5%) | −180.9 | −178.9 | 0.29 |
| AR SRX1067067 | LHSAR Prostate | 884 / 21815 (4.1%) | 20325 / 218150 (9.3%) | −180.4 | −178.4 | 0.43 |
| RELA SRX7054661 | HAEC Cardiovascular | 830 / 21815 (3.8%) | 19537 / 218150 (9.0%) | −180.1 | −178.1 | 0.42 |
| VGLL1 SRX24602130 | BT-20 Breast | 548 / 21815 (2.5%) | 15301 / 218150 (7.0%) | −180.0 | −178.0 | 0.36 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 501 / 21815 (2.3%) | 14558 / 218150 (6.7%) | −180.0 | −178.0 | 0.34 |
| AR SRX9469988 | LAPC-4 Prostate | 701 / 21815 (3.2%) | 17625 / 218150 (8.1%) | −179.6 | −177.6 | 0.40 |
| ESR1 SRX20282955 | MCF-7 Breast | 563 / 21815 (2.6%) | 15519 / 218150 (7.1%) | −179.5 | −177.5 | 0.36 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 475 / 21815 (2.2%) | 14122 / 218150 (6.5%) | −179.4 | −177.4 | 0.34 |
| ARID5B SRX3230377 | Hep G2 Liver | 1283 / 21815 (5.9%) | 25802 / 218150 (11.8%) | −179.2 | −177.2 | 0.50 |
| TLE3 SRX4815192 | MCF-7 Breast | 479 / 21815 (2.2%) | 14174 / 218150 (6.5%) | −179.1 | −177.1 | 0.34 |
| KDM1A SRX10637290 | MDA-MB-231 Breast | 670 / 21815 (3.1%) | 17137 / 218150 (7.9%) | −179.0 | −177.0 | 0.39 |
| BRD4 SRX327752 | U-87 MG Neural | 932 / 21815 (4.3%) | 20949 / 218150 (9.6%) | −178.9 | −176.9 | 0.44 |
| NR3C1 SRX2609667 | HASM2 Lung | 513 / 21815 (2.4%) | 14709 / 218150 (6.7%) | −178.9 | −176.9 | 0.35 |
| ERG SRX063921 | K-562 Blood | 1819 / 21815 (8.3%) | 8308 / 218150 (3.8%) | −178.5 | −176.5 | 2.19 |
| MLXIP SRX5391034 | Skeletal myotubes Muscle | 639 / 21815 (2.9%) | 16647 / 218150 (7.6%) | −178.4 | −176.4 | 0.38 |
| SMARCA4 SRX5716469 | Neural progenitor cells Neural | 354 / 21815 (1.6%) | 12091 / 218150 (5.5%) | −178.4 | −176.4 | 0.29 |
| RELA SRX7054670 | HAEC Cardiovascular | 564 / 21815 (2.6%) | 15489 / 218150 (7.1%) | −178.2 | −176.2 | 0.36 |
| CTNNB1 SRX833403 | hESC H1 Pluripotent stem cell | 133 / 21815 (0.6%) | 7942 / 218150 (3.6%) | −177.9 | −175.9 | 0.17 |
| ESR1 SRX20282946 | MCF-7 Breast | 317 / 21815 (1.5%) | 11423 / 218150 (5.2%) | −177.6 | −175.6 | 0.28 |
| KAT7 DRX234808 | 293 Kidney | 939 / 21815 (4.3%) | 2887 / 218150 (1.3%) | −177.0 | −175.0 | 3.25 |
| ESR1 SRX371474 | BT-474 Breast | 245 / 21815 (1.1%) | 10113 / 218150 (4.6%) | −176.9 | −174.9 | 0.24 |
| PROX1 SRX3230397 | Hep G2 Liver | 379 / 21815 (1.7%) | 12461 / 218150 (5.7%) | −176.8 | −174.8 | 0.30 |
| BMI1 SRX644729 | 293 Kidney | 282 / 21815 (1.3%) | 160 / 218150 (0.1%) | −176.7 | −174.7 | 17.63 |
| PTEN SRX5416007 | SMMC-7721 Liver | 2167 / 21815 (9.9%) | 10787 / 218150 (4.9%) | −175.9 | −173.9 | 2.01 |
| EP300 ERX626821 | U-937 Blood | 1497 / 21815 (6.9%) | 6231 / 218150 (2.9%) | −175.8 | −173.9 | 2.40 |
| FOXA1 SRX100477 | Hep G2 Liver | 600 / 21815 (2.8%) | 15958 / 218150 (7.3%) | −175.8 | −173.8 | 0.38 |
| HMG20A SRX2630163 | Hep G2 Liver | 290 / 21815 (1.3%) | 10884 / 218150 (5.0%) | −175.6 | −173.6 | 0.27 |
| ING2 SRX286201 | RKO Digestive tract | 1716 / 21815 (7.9%) | 7673 / 218150 (3.5%) | −175.6 | −173.6 | 2.24 |
| NANOG SRX017277 | hESC H1 Pluripotent stem cell | 195 / 21815 (0.9%) | 9114 / 218150 (4.2%) | −175.2 | −173.2 | 0.21 |
| ESR1 SRX2881002 | MCF-7 Breast | 509 / 21815 (2.3%) | 14518 / 218150 (6.7%) | −175.1 | −173.2 | 0.35 |
| ESR1 SRX20282940 | MCF-7 Breast | 590 / 21815 (2.7%) | 15776 / 218150 (7.2%) | −175.1 | −173.1 | 0.37 |
| FOXA1 SRX1447317 | MCF-7 Breast | 341 / 21815 (1.6%) | 11757 / 218150 (5.4%) | −175.0 | −173.1 | 0.29 |
| SMARCA4 SRX5075174 | Neural progenitor cells Neural | 857 / 21815 (3.9%) | 19710 / 218150 (9.0%) | −174.6 | −172.7 | 0.43 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 912 / 21815 (4.2%) | 2772 / 218150 (1.3%) | −174.5 | −172.5 | 3.29 |
| ERG SRX063922 | K-562 Blood | 1895 / 21815 (8.7%) | 8916 / 218150 (4.1%) | −174.4 | −172.5 | 2.13 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 472 / 21815 (2.2%) | 13902 / 218150 (6.4%) | −174.4 | −172.4 | 0.34 |
| EP300 ERX626811 | U-937 Blood | 1494 / 21815 (6.8%) | 6241 / 218150 (2.9%) | −174.3 | −172.4 | 2.39 |
| RBFOX2 SRX4708082 | K-562 Blood | 2855 / 21815 (13.1%) | 15906 / 218150 (7.3%) | −174.3 | −172.4 | 1.79 |
| FOXA1 SRX190282 | A549 Lung | 359 / 21815 (1.6%) | 12040 / 218150 (5.5%) | −174.3 | −172.3 | 0.30 |
| STAT5B SRX831881 | CD8+ T cells Blood | 285 / 21815 (1.3%) | 174 / 218150 (0.1%) | −173.8 | −171.8 | 16.38 |
| ESR1 SRX4367192 | MCF-7 Breast | 1076 / 21815 (4.9%) | 22737 / 218150 (10.4%) | −173.5 | −171.5 | 0.47 |
| FOXA1 SRX1787651 | MCF-7 Breast | 304 / 21815 (1.4%) | 11063 / 218150 (5.1%) | −173.4 | −171.5 | 0.27 |
| TEAD1 SRX716558 | SF268 Neural | 264 / 21815 (1.2%) | 10353 / 218150 (4.7%) | −173.4 | −171.5 | 0.25 |
| WDR5 SRX5416008 | SMMC-7721 Liver | 2156 / 21815 (9.9%) | 10771 / 218150 (4.9%) | −173.4 | −171.4 | 2.00 |
| ESR1 SRX10365535 | MCF-7 Breast | 448 / 21815 (2.1%) | 13474 / 218150 (6.2%) | −173.3 | −171.3 | 0.33 |
| JADE3 DRX234809 | 293 Kidney | 1234 / 21815 (5.7%) | 4635 / 218150 (2.1%) | −173.2 | −171.2 | 2.66 |
| STAT1 SRX23678707 | K-562 Blood | 1735 / 21815 (8.0%) | 7857 / 218150 (3.6%) | −172.9 | −171.0 | 2.21 |
| Epitope tags SRX15939725 | RD Muscle | 409 / 21815 (1.9%) | 12825 / 218150 (5.9%) | −172.8 | −170.8 | 0.32 |
| JUNB SRX10119385 | MCF 10A Breast | 232 / 21815 (1.1%) | 9737 / 218150 (4.5%) | −172.5 | −170.6 | 0.24 |
| ESR1 SRX371475 | BT-474 Breast | 280 / 21815 (1.3%) | 10610 / 218150 (4.9%) | −172.5 | −170.6 | 0.26 |
| ESR1 SRX2881000 | MCF-7 Breast | 476 / 21815 (2.2%) | 13897 / 218150 (6.4%) | −172.5 | −170.5 | 0.34 |
| RELA SRX7054616 | HAEC Cardiovascular | 430 / 21815 (2.0%) | 13156 / 218150 (6.0%) | −172.4 | −170.5 | 0.33 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 264 / 21815 (1.2%) | 10321 / 218150 (4.7%) | −172.4 | −170.5 | 0.26 |
| FOXA1 SRX3923517 | MCF-7 Breast | 382 / 21815 (1.8%) | 12361 / 218150 (5.7%) | −172.4 | −170.5 | 0.31 |
| TEAD1 SRX3401272 | MCF-7 Breast | 415 / 21815 (1.9%) | 12902 / 218150 (5.9%) | −172.3 | −170.3 | 0.32 |
| FOXA1 SRX1787655 | MCF-7 Breast | 272 / 21815 (1.2%) | 10452 / 218150 (4.8%) | −172.1 | −170.1 | 0.26 |
| FOXA1 SRX5323843 | MCF-7 Breast | 276 / 21815 (1.3%) | 10521 / 218150 (4.8%) | −172.0 | −170.1 | 0.26 |
| ESR1 SRX2943589 | MCF-7 Breast | 277 / 21815 (1.3%) | 10539 / 218150 (4.8%) | −171.9 | −170.0 | 0.26 |
| MEN1 SRX11712604 | K-562 Blood | 1710 / 21815 (7.8%) | 7712 / 218150 (3.5%) | −171.8 | −169.9 | 2.22 |
| YAP1 SRX10119388 | MDA-MB-231 Breast | 372 / 21815 (1.7%) | 12165 / 218150 (5.6%) | −171.5 | −169.6 | 0.31 |
| AR SRX9109110 | MDA-MB-453 Breast | 1000 / 21815 (4.6%) | 21600 / 218150 (9.9%) | −171.4 | −169.4 | 0.46 |
| JUND SRX150408 | HeLa Uterus | 471 / 21815 (2.2%) | 13776 / 218150 (6.3%) | −171.3 | −169.4 | 0.34 |
| CEBPB SRX2194249 | SUM 159PT Breast | 522 / 21815 (2.4%) | 14583 / 218150 (6.7%) | −171.3 | −169.3 | 0.36 |
| ATF1 SRX11470442 | Mesenchymal stem cells Others | 679 / 21815 (3.1%) | 16968 / 218150 (7.8%) | −171.0 | −169.1 | 0.40 |
| SMARCA4 SRX8588625 | Pulmonary artery endothelial cells Cardiovascular | 560 / 21815 (2.6%) | 15165 / 218150 (7.0%) | −171.0 | −169.1 | 0.37 |
| RELA SRX7054615 | HAEC Cardiovascular | 559 / 21815 (2.6%) | 15143 / 218150 (6.9%) | −170.9 | −168.9 | 0.37 |
| FOXA1 SRX3923516 | MCF-7 Breast | 392 / 21815 (1.8%) | 12474 / 218150 (5.7%) | −170.8 | −168.9 | 0.31 |
| ARID1A SRX5089379 | MCF-7 Breast | 543 / 21815 (2.5%) | 14891 / 218150 (6.8%) | −170.6 | −168.7 | 0.36 |
| FOXA1 SRX028634 | MCF-7 Breast | 270 / 21815 (1.2%) | 10372 / 218150 (4.8%) | −170.6 | −168.7 | 0.26 |
| FOS SRX3322636 | MCF-7 Breast | 353 / 21815 (1.6%) | 11815 / 218150 (5.4%) | −170.5 | −168.6 | 0.30 |
| ESR1 SRX10365533 | MCF-7 Breast | 257 / 21815 (1.2%) | 10132 / 218150 (4.6%) | −170.5 | −168.6 | 0.25 |
| GATAD2A SRX2636506 | Hep G2 Liver | 687 / 21815 (3.1%) | 17070 / 218150 (7.8%) | −170.5 | −168.6 | 0.40 |
| FOXA1 SRX11222438 | MCF-7 Breast | 288 / 21815 (1.3%) | 10689 / 218150 (4.9%) | −170.5 | −168.6 | 0.27 |
| ESR1 SRX4451213 | MCF-7 Breast | 553 / 21815 (2.5%) | 15036 / 218150 (6.9%) | −170.4 | −168.5 | 0.37 |
| MITF SRX7368256 | Hermes 3C Epidermis | 1039 / 21815 (4.8%) | 22097 / 218150 (10.1%) | −170.4 | −168.5 | 0.47 |
| GATA3 SRX6712581 | MCF-7 Breast | 452 / 21815 (2.1%) | 13420 / 218150 (6.2%) | −169.8 | −167.9 | 0.34 |
| LEO1 SRX15147190 | DLD-1 Digestive tract | 1050 / 21815 (4.8%) | 3600 / 218150 (1.7%) | −169.8 | −167.9 | 2.92 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 521 / 21815 (2.4%) | 14513 / 218150 (6.7%) | −169.7 | −167.8 | 0.36 |
| LARP7 SRX2198835 | HeLa Uterus | 2534 / 21815 (11.6%) | 13630 / 218150 (6.2%) | −169.7 | −167.7 | 1.86 |
| EP300 SRX22550927 | CDS1 Bone | 808 / 21815 (3.7%) | 18804 / 218150 (8.6%) | −169.6 | −167.7 | 0.43 |
| RELA SRX7054671 | HAEC Cardiovascular | 758 / 21815 (3.5%) | 18078 / 218150 (8.3%) | −169.5 | −167.6 | 0.42 |
| FOXA1 SRX1787652 | MCF-7 Breast | 336 / 21815 (1.5%) | 11483 / 218150 (5.3%) | −169.3 | −167.4 | 0.29 |
| FOXA1 SRX3923518 | MCF-7 Breast | 376 / 21815 (1.7%) | 12152 / 218150 (5.6%) | −169.1 | −167.2 | 0.31 |
| RELA SRX2207671 | HUVEC Cardiovascular | 274 / 21815 (1.3%) | 10393 / 218150 (4.8%) | −169.1 | −167.2 | 0.26 |
| SSRP1 SRX3436566 | HT-1080 Bone | 374 / 21815 (1.7%) | 428 / 218150 (0.2%) | −169.1 | −167.2 | 8.74 |
| RELA SRX5938177 | FaDu Others | 500 / 21815 (2.3%) | 14157 / 218150 (6.5%) | −169.0 | −167.1 | 0.35 |
| WWTR1 SRX10119378 | MCF 10A Breast | 580 / 21815 (2.7%) | 15392 / 218150 (7.1%) | −168.8 | −166.9 | 0.38 |
| BRD4 SRX327751 | U-87 MG Neural | 1473 / 21815 (6.8%) | 27841 / 218150 (12.8%) | −168.6 | −166.7 | 0.53 |
| MED1 SRX4937336 | HCT 116 Digestive tract | 1911 / 21815 (8.8%) | 9161 / 218150 (4.2%) | −168.6 | −166.7 | 2.09 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 516 / 21815 (2.4%) | 14391 / 218150 (6.6%) | −168.5 | −166.6 | 0.36 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 270 / 21815 (1.2%) | 10286 / 218150 (4.7%) | −168.0 | −166.1 | 0.26 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 626 / 21815 (2.9%) | 1414 / 218150 (0.6%) | −167.9 | −166.1 | 4.43 |
| CDK9 SRX7366783 | MCF-7 Breast | 278 / 21815 (1.3%) | 174 / 218150 (0.1%) | −167.9 | −166.0 | 15.98 |
| ARID1A SRX5679787 | 12Z Others | 209 / 21815 (1.0%) | 9157 / 218150 (4.2%) | −167.7 | −165.8 | 0.23 |
| STAT3 SRX2020842 | HCC70 Breast | 953 / 21815 (4.4%) | 20788 / 218150 (9.5%) | −167.7 | −165.8 | 0.46 |
| CEBPA SRX4705113 | MOLM-13 Blood | 1221 / 21815 (5.6%) | 24460 / 218150 (11.2%) | −167.6 | −165.7 | 0.50 |
| FOXA1 SRX6878603 | LNCAP Prostate | 603 / 21815 (2.8%) | 15695 / 218150 (7.2%) | −167.5 | −165.6 | 0.38 |
| ESR1 SRX330069 | MCF-7 Breast | 337 / 21815 (1.5%) | 11437 / 218150 (5.2%) | −167.4 | −165.5 | 0.29 |
| EP300 SRX176885 | MCF-7 Breast | 286 / 21815 (1.3%) | 10555 / 218150 (4.8%) | −167.4 | −165.5 | 0.27 |
| ESR1 SRX330067 | MCF-7 Breast | 502 / 21815 (2.3%) | 14114 / 218150 (6.5%) | −166.9 | −165.0 | 0.36 |
| Epitope tags SRX5877912 | U2OS Bone | 2882 / 21815 (13.2%) | 45174 / 218150 (20.7%) | −166.8 | −165.0 | 0.64 |
| HOXC5 SRX2731653 | PC-3 Prostate | 431 / 21815 (2.0%) | 12973 / 218150 (5.9%) | −166.7 | −164.8 | 0.33 |
| FOXA1 SRX028635 | MCF-7 Breast | 278 / 21815 (1.3%) | 10388 / 218150 (4.8%) | −166.7 | −164.8 | 0.27 |
| NR2F2 SRX190293 | MCF-7 Breast | 584 / 21815 (2.7%) | 15373 / 218150 (7.0%) | −166.6 | −164.8 | 0.38 |
| FOXA1 SRX3931033 | MCF-7 Breast | 351 / 21815 (1.6%) | 11638 / 218150 (5.3%) | −166.3 | −164.4 | 0.30 |
| ESR1 SRX330070 | MCF-7 Breast | 285 / 21815 (1.3%) | 10496 / 218150 (4.8%) | −166.2 | −164.3 | 0.27 |
| CEBPA SRX097095 | U-937 Blood | 414 / 21815 (1.9%) | 12678 / 218150 (5.8%) | −166.1 | −164.2 | 0.33 |
| FOSL1 SRX2585779 | MDA-MB-231 Breast | 266 / 21815 (1.2%) | 10144 / 218150 (4.7%) | −165.7 | −163.9 | 0.26 |
| NR3C1 SRX9298951 | Lung cancer cell line Lung | 347 / 21815 (1.6%) | 11551 / 218150 (5.3%) | −165.7 | −163.8 | 0.30 |
| NR3C1 SRX2609668 | HASM2 Lung | 417 / 21815 (1.9%) | 12710 / 218150 (5.8%) | −165.7 | −163.8 | 0.33 |
| RELA SRX7055006 | HAEC Cardiovascular | 487 / 21815 (2.2%) | 13827 / 218150 (6.3%) | −165.5 | −163.6 | 0.35 |
| SMARCA4 SRX5982364 | A549 Lung | 167 / 21815 (0.8%) | 8279 / 218150 (3.8%) | −165.4 | −163.6 | 0.20 |
| FOXA1 SRX1161203 | T-47D Breast | 396 / 21815 (1.8%) | 12358 / 218150 (5.7%) | −165.3 | −163.4 | 0.32 |
| GATA2 SRX150427 | HUVEC Cardiovascular | 294 / 21815 (1.3%) | 10621 / 218150 (4.9%) | −165.2 | −163.3 | 0.28 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 351 / 21815 (1.6%) | 11598 / 218150 (5.3%) | −165.0 | −163.1 | 0.30 |
| ESR1 SRX2912055 | MCF-7 Breast | 213 / 21815 (1.0%) | 9149 / 218150 (4.2%) | −164.9 | −163.1 | 0.23 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 374 / 21815 (1.7%) | 11970 / 218150 (5.5%) | −164.7 | −162.8 | 0.31 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 377 / 21815 (1.7%) | 12012 / 218150 (5.5%) | −164.5 | −162.6 | 0.31 |
| SMARCA4 SRX5075168 | Neural progenitor cells Neural | 768 / 21815 (3.5%) | 18027 / 218150 (8.3%) | −164.5 | −162.6 | 0.43 |
| NFYB SRX16608147 | HeLa Uterus | 299 / 21815 (1.4%) | 234 / 218150 (0.1%) | −164.5 | −162.6 | 12.78 |
| DPF2 SRX3927297 | MOLM-13 Blood | 639 / 21815 (2.9%) | 16117 / 218150 (7.4%) | −164.3 | −162.4 | 0.40 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 859 / 21815 (3.9%) | 2613 / 218150 (1.2%) | −164.1 | −162.2 | 3.29 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 708 / 21815 (3.2%) | 17116 / 218150 (7.8%) | −163.7 | −161.8 | 0.41 |
| Epitope tags SRX10549777 | K-562 Blood | 2925 / 21815 (13.4%) | 16782 / 218150 (7.7%) | −163.6 | −161.7 | 1.74 |
| FOXA1 SRX15430999 | T-47D Breast | 616 / 21815 (2.8%) | 15742 / 218150 (7.2%) | −163.6 | −161.7 | 0.39 |
| EP300 SRX1012648 | MCF-7 Breast | 269 / 21815 (1.2%) | 10131 / 218150 (4.6%) | −163.5 | −161.7 | 0.27 |
| ESR1 SRX20282971 | MCF-7 Breast | 558 / 21815 (2.6%) | 14857 / 218150 (6.8%) | −163.5 | −161.6 | 0.38 |
| RELA SRX7054664 | HAEC Cardiovascular | 539 / 21815 (2.5%) | 14562 / 218150 (6.7%) | −163.3 | −161.5 | 0.37 |
| SMARCA4 SRX5982340 | A549 Lung | 219 / 21815 (1.0%) | 9210 / 218150 (4.2%) | −163.3 | −161.4 | 0.24 |
| NANOG SRX702040 | hESC HUES64 Pluripotent stem cell | 102 / 21815 (0.5%) | 6854 / 218150 (3.1%) | −163.1 | −161.2 | 0.15 |
| NANOG SRX2881137 | hESC H9 Pluripotent stem cell | 152 / 21815 (0.7%) | 7901 / 218150 (3.6%) | −162.7 | −160.9 | 0.19 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 435 / 21815 (2.0%) | 12894 / 218150 (5.9%) | −162.6 | −160.8 | 0.34 |
| FOXA1 SRX5203303 | MCF-7 Breast | 189 / 21815 (0.9%) | 8619 / 218150 (4.0%) | −162.4 | −160.5 | 0.22 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 370 / 21815 (1.7%) | 11824 / 218150 (5.4%) | −162.3 | −160.4 | 0.31 |
| CHD7 SRX3581511 | iPSC derived neural cells Pluripotent stem cell | 165 / 21815 (0.8%) | 8149 / 218150 (3.7%) | −162.3 | −160.4 | 0.20 |
| EP300 SRX10976215 | A549 Lung | 510 / 21815 (2.3%) | 14048 / 218150 (6.4%) | −161.7 | −159.8 | 0.36 |
| SMARCA2 SRX5982361 | A549 Lung | 175 / 21815 (0.8%) | 8319 / 218150 (3.8%) | −161.5 | −159.7 | 0.21 |
| DDIT3 SRX11379509 | Liposarcoma, Myxoid Adipocyte | 423 / 21815 (1.9%) | 12662 / 218150 (5.8%) | −161.4 | −159.5 | 0.33 |
| CEBPB SRX2194247 | SUM 159PT Breast | 460 / 21815 (2.1%) | 13250 / 218150 (6.1%) | −161.3 | −159.5 | 0.35 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 323 / 21815 (1.5%) | 10998 / 218150 (5.0%) | −161.3 | −159.4 | 0.29 |
| NANOG SRX5286326 | hESC WIBR2 Pluripotent stem cell | 472 / 21815 (2.2%) | 13439 / 218150 (6.2%) | −161.3 | −159.4 | 0.35 |
| BRD4 SRX3031983 | MV-4-11 Blood | 740 / 21815 (3.4%) | 17489 / 218150 (8.0%) | −161.2 | −159.4 | 0.42 |
| MED1 SRX4937340 | HCT 116 Digestive tract | 1907 / 21815 (8.7%) | 9306 / 218150 (4.3%) | −161.2 | −159.4 | 2.05 |
| NR3C1 SRX10976921 | A549 Lung | 395 / 21815 (1.8%) | 12185 / 218150 (5.6%) | −160.8 | −159.0 | 0.32 |
| ESR1 SRX20282953 | MCF-7 Breast | 465 / 21815 (2.1%) | 13313 / 218150 (6.1%) | −160.8 | −158.9 | 0.35 |
| INTS3 SRX3640569 | HeLa Uterus | 1506 / 21815 (6.9%) | 6584 / 218150 (3.0%) | −160.7 | −158.9 | 2.29 |
| FOXA1 SRX3923519 | MCF-7 Breast | 347 / 21815 (1.6%) | 11374 / 218150 (5.2%) | −160.4 | −158.6 | 0.31 |
| TEAD4 SRX10640863 | SK-MEL-147 Epidermis | 750 / 21815 (3.4%) | 17603 / 218150 (8.1%) | −160.4 | −158.5 | 0.43 |
| KDM4C SRX424010 | KYSE-150 Digestive tract | 1458 / 21815 (6.7%) | 6279 / 218150 (2.9%) | −160.2 | −158.4 | 2.32 |
| CEBPB SRX3584202 | Epididymis Gonad | 519 / 21815 (2.4%) | 14132 / 218150 (6.5%) | −160.1 | −158.3 | 0.37 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 465 / 21815 (2.1%) | 13284 / 218150 (6.1%) | −160.0 | −158.2 | 0.35 |
| EP300 SRX147007 | IMR-90 Lung | 481 / 21815 (2.2%) | 13536 / 218150 (6.2%) | −159.9 | −158.1 | 0.36 |
| TEAD4 SRX10640860 | SK-MEL-147 Epidermis | 773 / 21815 (3.5%) | 17915 / 218150 (8.2%) | −159.9 | −158.1 | 0.43 |
| OTX2 SRX702045 | hESC HUES64 Pluripotent stem cell | 423 / 21815 (1.9%) | 12603 / 218150 (5.8%) | −159.8 | −157.9 | 0.34 |
| GATA3 SRX100559 | T-47D Breast | 624 / 21815 (2.9%) | 15710 / 218150 (7.2%) | −159.5 | −157.7 | 0.40 |
| EP300 SRX212184 | Lung fibroblasts Lung | 483 / 21815 (2.2%) | 13544 / 218150 (6.2%) | −159.3 | −157.4 | 0.36 |
| FOSL1 SRX190212 | HCT 116 Digestive tract | 641 / 21815 (2.9%) | 15952 / 218150 (7.3%) | −159.2 | −157.3 | 0.40 |
| ESR1 SRX10365558 | MCF-7 Breast | 391 / 21815 (1.8%) | 12063 / 218150 (5.5%) | −159.1 | −157.3 | 0.32 |
| EP300 SRX100544 | Hep G2 Liver | 426 / 21815 (2.0%) | 12624 / 218150 (5.8%) | −158.9 | −157.1 | 0.34 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 1454 / 21815 (6.7%) | 6280 / 218150 (2.9%) | −158.8 | −157.0 | 2.32 |
| FOXA1 SRX1961158 | T-47D Breast | 563 / 21815 (2.6%) | 14762 / 218150 (6.8%) | −158.7 | −156.9 | 0.38 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 423 / 21815 (1.9%) | 12568 / 218150 (5.8%) | −158.7 | −156.9 | 0.34 |
| SMARCC1 SRX3927288 | EOL-1 Blood | 1334 / 21815 (6.1%) | 25560 / 218150 (11.7%) | −158.6 | −156.7 | 0.52 |
| RELA SRX7054614 | HAEC Cardiovascular | 781 / 21815 (3.6%) | 17979 / 218150 (8.2%) | −158.5 | −156.7 | 0.43 |
| CEBPB SRX190345 | MCF-7 Breast | 446 / 21815 (2.0%) | 12926 / 218150 (5.9%) | −158.5 | −156.7 | 0.35 |
| FOXA1 SRX5323829 | T-47D Breast | 323 / 21815 (1.5%) | 10907 / 218150 (5.0%) | −158.5 | −156.7 | 0.30 |
| ESR1 SRX1531796 | MCF-7 Breast | 307 / 21815 (1.4%) | 10627 / 218150 (4.9%) | −158.4 | −156.5 | 0.29 |
| ESR1 SRX3123829 | MCF-7 Breast | 332 / 21815 (1.5%) | 11053 / 218150 (5.1%) | −158.3 | −156.5 | 0.30 |
| YAP1 SRX10119387 | MDA-MB-231 Breast | 417 / 21815 (1.9%) | 12455 / 218150 (5.7%) | −158.2 | −156.4 | 0.33 |
| RELA SRX7054621 | HAEC Cardiovascular | 458 / 21815 (2.1%) | 13104 / 218150 (6.0%) | −158.0 | −156.2 | 0.35 |
Showing first 500 of 23133 rows.